Abstract
Small interfering RNAs (siRNAs) have the potential to treat a broad range of diseases. siRNAs need to be extensively chemically modified to improve their bioavailability, safety, and stability in vivo. However, chemical modifications variably impact target silencing for different siRNA sequences, making the activity of chemically modified siRNA difficult to predict. Here, we systematically evaluated the impact of 3′ terminal modifications (2′-O-methyl versus 2′-fluoro) on guide strands of different length and showed that 3′ terminal 2′-O-methyl modification negatively impacts activity for >60% of siRNA sequences tested but only in the context of 20- and not 19- or 21-nt-long guide strands. These results indicate that sequence, modification pattern, and structure may cooperatively affect target silencing. Interestingly, the introduction of an extra 2′-fluoro modification in the seed region at guide strand position 5, but not 7, may partially compensate for the negative impact of 3′ terminal 2′-O-methyl modification. Molecular modeling analysis suggests that 2′-O-methyl modification may impair guide strand interactions within the PAZ domain of argonaute-2, which may affect target recognition and cleavage, specifically when guide strands are 20-nt long. Our findings emphasize the complex nature of modified RNA-protein interactions and contribute to design principles for chemically modified siRNAs.
Highlights
Small interfering RNA interacts with the RNA-induced silencing complex (RISC) to degrade complementary mRNA and prevent protein translation, making it a powerful tool for silencing disease-causing genes.[1]
Impacts Target Silencing for Fully Modified, Asymmetric Small interfering RNA (siRNA) To evaluate the impact of position-specific chemical modification changes, we utilized an asymmetric siRNA, fully chemically modified with alternating 20-OMe and 20-F groups (Figure 1)
To date, there are no publications comparing the impacts of 30 guide strand terminal 20-OMe versus 20-F modification on siRNA activity
Summary
Small interfering RNA (siRNA) interacts with the RNA-induced silencing complex (RISC) to degrade complementary mRNA and prevent protein translation, making it a powerful tool for silencing disease-causing genes.[1]. We demonstrate that 30 terminal 20-OMe modification of 20but not 19- or 21-mer guide strands may reduce the activity of fully modified, asymmetric siRNAs and that this negative effect may be partially compensated by including an additional 20-F modification at guide strand position 5. 266 Molecular Therapy: Nucleic Acids Vol 21 September 2020 a 2020 The Authors. Complexity and dynamic nature of chemically modified siRNA-RISC interactions
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.